Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Nueterra Capital is a venture capital firm established in 1997 by Jim Schultz in Leawood, Kansas. The firm has a strong focus on early-stage investments in healthcare and technology companies, particularly those positioned for rapid growth. Over the years, Nueterra has deployed more than $850 million across various healthcare verticals, resulting in the creation of approximately $4.5 billion in value. The firm operates with a team of 31 professionals, including 9 partners, and maintains a portfolio of 37 to 39 companies.
In addition to its headquarters in Leawood, Nueterra Capital has a presence in Dallas, Texas. The firm has historically operated over 150 surgery centers, which provides them with deep operational expertise in the healthcare sector. This experience enhances their ability to support portfolio companies beyond just capital investment, offering operational insights and strategic guidance.
Nueterra Capital's investment strategy is centered on addressing inefficiencies in healthcare administration, diagnosis, and delivery. The firm primarily invests in sectors such as fintech, healthcare, SaaS, and vertical SaaS, with a particular emphasis on healthcare technology solutions. Their check sizes range from $1 million to $15 million, targeting companies at the seed, Series A, and Series B stages.
The firm focuses on areas including healthcare data interoperability, care coordination, revenue cycle management, patient engagement, and insurance verification. Nueterra Capital seeks innovative solutions that alleviate administrative and clinical friction points, particularly in U.S. Emerging Markets. Their investment thesis is built around enhancing healthcare delivery through technology, aiming to improve operational efficiency and patient outcomes.
Nueterra Capital has a diverse portfolio of companies, with notable investments including:
Nueterra's portfolio has created significant value, with $4.5 billion generated and $3 billion distributed to investors. Their latest fund achieved a gross IRR of 31%, including at least one company valued at over $1 billion.
Dan Tasset: Chairman of Nueterra Capital, brings extensive experience in healthcare investment and operations.
Jeremy Tasset: Chief Executive Officer, responsible for overseeing the firm's strategic direction and investment activities.
Emmanuel Emah-Emeni: Managing Director, focuses on sourcing and managing investments within the healthcare sector.
George Lester: Senior Vice President, involved in portfolio management and operational support for portfolio companies.
Brandon Tasset: Investment Partner, contributes to deal sourcing and evaluation.
Travis Tasset: Investment Partner, works on investment strategy and portfolio development.
To pitch Nueterra Capital, founders should use the contact form available at https://www.nueterra.com/contact. It is recommended to include a comprehensive pitch deck that outlines the business model, market opportunity, and financial projections. Response times may vary, so founders should be prepared for potential follow-up discussions.
On December 1, 2025, Nueterra Capital made its latest investment, continuing its active deployment of capital in the healthcare sector. Over the past year, the firm has completed 8 investments, reflecting its commitment to supporting innovative healthcare solutions.
Q?
What are Nueterra Capital's investment criteria?
Nueterra Capital invests in early-stage healthcare and technology companies, focusing on sectors such as fintech, healthcare, SaaS, and vertical SaaS. They typically provide check sizes ranging from $1 million to $15 million.
Q?
How can startups apply or pitch to Nueterra Capital?
Startups can pitch to Nueterra Capital through their contact page at https://www.nueterra.com/contact. It is advisable to include a detailed business plan and financial projections in the pitch.
Q?
What makes Nueterra Capital different from other venture firms?
Nueterra Capital's deep operational expertise in healthcare, stemming from their history of managing over 150 surgery centers, allows them to provide significant operational support beyond capital investment.
Q?
What is the geographic scope of Nueterra Capital's investments?
Nueterra Capital primarily invests in companies located within U.S. Emerging Markets, focusing on innovative healthcare solutions.
Q?
What is the firm's post-investment involvement like?
Nueterra Capital offers operational support and strategic guidance to its portfolio companies, leveraging their extensive experience in healthcare operations.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.